Skip to main content

Advertisement

Table 6 CD4 tests performed per month in health facilities providing ART on-site with data available

From: The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

  Malawi Uganda Zimbabwe
  Primary Secondary Tertiary Primary Secondary Tertiary Primary Secondary
All facilities (n = 2) (n = 1) (n = 1) (n = 4) (n = 14$) (n = 1) (n = 7) (n = 6)
 CD4s per month 84 (77–91) 57 831 40 (27–141) 82 (19–152) 388 10 (6–30) 171 (12–312)
 Adults* on ART 201; missing 9,600 17,453 189 (74–705) 576 (336–874) 2,412 263 (129–1,845) 2,800 (1,976-3,726)
 Adults initiating ART per month 46 (40–52) 478 597 11 (7–22) 27 (12–34) 35 13 (6–20) 50 (40–100)
Facilities where adults initiating ART per month <5% total adults* on ART (n = 0) (n = 1) (n = 1) (n = 2) (n = 9$$) (n = 1) (n = 4) (n = 5)
 Estimated frequency of CD4s in adults* on ART**         
 At least 6-monthly   0 0 2 2 0 0 0
 Every 6 months to 1 year   0 0 0 2 1 0 1
 Every 1 to 2 years   0 1 0 2 0 1 1
 Less than once every 2 years   1 0 0 3 0 3 3
  1. Values are median (IQR) or n.
  2. Sample collection and testing was on-site at all facilities in Malawi, tertiary care facilities in Uganda and secondary care facilities in Zimbabwe. Samples were taken on-site and sent to a referral laboratory at all primary care facilities in Uganda and Zimbabwe.
  3. $Sample collection and testing on-site (n = 7), samples taken on-site and sent to a referral laboratory (n = 6), patients sent to a referral laboratory (n = 1).
  4. $$Sample collection and testing on-site (n = 4), samples taken on-site and sent to a referral laboratory (n = 4), patients sent to a referral laboratory (n = 1).
  5. *Current adult patients at facility (except for Malawi where numbers are all ART patients).
  6. **Estimated assuming constant number of patients on ART and constant rate of CD4-testing (includes all CD4s although some will be for initiation or in children). Of these facilities 0/1, 0/1 facilities in Malawi, 2/2, 6/9, 1/1 facilities in Uganda and 2/4, 2/5 facilities in Zimbabwe reported CD4-monitoring in adults was at least 6-monthly (across non-empty cells).